QC
ANIP icon

Quadrature Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Quadrature Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
+25,674
New +$2.06M 0.02% 484
2025
Q4 		– Sell
-4,320
Closed -$396K – 1242
2025
Q3 		$396K Buy
+4,320
New +$352K ﹤0.01% 597
2025
Q2 		– Sell
-5,892
Closed -$394K – 1030
2025
Q1 		$394K Buy
+5,892
New +$352K 0.01% 647

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrature Capital's ANIP Position: Q2 2026 in Review

Quadrature Capital opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 25,674 shares worth $2.13M. The stake represents 0.02% of the portfolio and ranks #484 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in ANIP as recently as Q3 2025.

Quadrature Capital first reported a position in ANIP in Q1 2025 and has held it in 3 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Quadrature Capital held 25,674 shares of ANI Pharmaceuticals worth $2.13M as of Q2 2026.
  • ANI Pharmaceuticals was a new Quadrature Capital position in Q2 2026.
  • ANI Pharmaceuticals made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #484 holding.
  • Quadrature Capital first reported a position in ANI Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.